29.09.21|Tamar van der Boom and Yoav Alkalay"Building a useful patent portfolio requires the company to define quantity and quality targets, for the short, medium, and long terms," write Tamar van der Boom and Yoav Alkalay of Pearl Cohen law firm
07.07.21|Nadav Tal Israel"The same resources and energies that you chose to direct into patent registration could have been invested in academic research, which could give you almost the same result," writes Edgify CTO Nadav Tal Israel
27.06.21|Ehud Hausman"Contrary to the common myth, in most leading countries including but not limited to the U.S., Europe (EPO), China, Korea and Japan, software-related inventions are patentable and enforceable," writes Ehud Hausman of Reinhold Cohn & Partners
05.11.20|Doron PeskinIsraeli companies that are interested in protecting their intellectual property, trademarks, and patents should quell their excitement as long as there are still no embassies established in both countries
13.12.19|Dov GreenbaumResearcher Dov Greenbaum examines the legal protections provided for big data and whether our insatiable internet appetites should be curbed to save the planet
15.08.19|Meir OrbachCorephotonics filed a patent-infringement lawsuit against Apple to a Northern California district court Wednesday. The Israeli company first sued Apple in 2017
10.06.19|Shahar IlanIn a list of top 100 global universities granted U.S. patents, Tel Aviv University dropped two places compared to 2017, ranking 66th with 37 patents. With 32 patents, Technion dropped to 75th place, compared to 35th place the year before
10.05.19|Dov GreenbaumFrom racehorse breeding to human medicine, CRISPR gene editing is the future. Researchers worldwide are racing for the patent
03.02.19|Lilach BaumerAround 340,000 patents were filed in the U.S. in 2018, almost 5,000 of them by Israeli inventors
03.02.19|Hagar Ravet and Lilach Baumer12% of all patents submitted by Intel in 2015-2018 originated in Israel, with the number rising to 13.5% in 2018
23.07.18|CTechIn September 2017, Allergan transferred six of its patents for blockbuster dry eye drug Restasis to the St. Regis Mohawk Tribe, hoping to protect the patents under the principle of sovereign immunity
31.10.17|Lilach BaumerThe generic drugmaker shed 67% of its market price over the last 12 months